global measles and rubella update october 2018 · somalia 2017 23394 somali epi/pol weekly update...
TRANSCRIPT
Global Measles and Rubella UpdateOctober 2018
Measles
Number of Reported Measles Cases by WHO Regions
2018
RegionMember States*
Suspected cases
Measles cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 42/47 40895 23753 13187 5364 5202 2975 4264 5067 3556 2562 1634 1695 1303 697 0 0 0 2018-10
AMR 30/35 22222 6672 0 0 6672 3 16 84 152 291 216 411 137 5362 0 0 0 2018-10
EMR 20/21 33843 17884 4782 4701 8401 2228 1739 2620 2647 3032 2112 2127 1006 373 0 0 0 2018-10
EUR 53/53 61717 52958 28976 2022 21960 5942 6884 7638 7831 8862 7210 5149 3427 15 0 0 0 2018-10
SEAR 11/11 75073 53599 47402 3678 2519 6590 6022 10890 10312 9634 4580 2777 2506 288 0 0 0 2018-10
WPR 26/27 48183 18311 10952 479 6880 1928 2485 3390 3251 2964 2131 1404 750 8 0 0 0 2018-10
Total 182/194 281933 17317710529
916244 51634 19666 21410 29689 27749 27345 17883 13563 9129 6743 0 0 0
2017
RegionMember States*
Suspected cases
Measles cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 43/47 51561 24834 11007 8841 4986 3215 2896 3647 2370 2026 1859 1475 1412 1519 1695 1315 1405 2018-10
AMR 31/35 10881 895 0 0 895 1 8 19 13 5 0 0 1 1 0 0 847 2018-10
EMR 20/21 36139 12777 1918 693 10166 1103 1080 1296 1280 1460 1057 1061 812 706 941 950 1031 2018-10
EUR 53/53 30930 24390 4419 6053 13918 1422 1873 3004 2885 2920 2572 1380 868 965 1327 2352 2822 2018-10
SEAR 11/11 99117 76429 55532 15043 5854 8639 9645 13057 10320 7516 4337 3639 4240 3357 2913 4246 4520 2018-10
WPR 26/27 53130 10296 2692 107 7497 778 894 1501 1222 1120 800 772 700 725 770 617 397 2018-10
Total 184/194 281758 149621 75568 30737 43316 15158 16396 22524 18090 15047 10625 8327 8033 7273 7646 9480 11022
Notes: Based on data received 2018-10 - This is surveillance data, hence for the last month, the data may be incomplete. * Member States
Reporting / Total Member States in Region
2018
RegionMember States*
Suspected cases
Measles cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 42/47 40895 23753 13187 5364 5202 2975 4264 5067 3556 2562 1634 1695 1303 697 0 0 0 2018-10
AMR 30/35 22222 6672 0 0 6672 3 16 84 152 291 216 411 137 5362 0 0 0 2018-10
EMR 20/21 33843 17884 4782 4701 8401 2228 1739 2620 2647 3032 2112 2127 1006 373 0 0 0 2018-10
EUR 53/53 61717 52958 28976 2022 21960 5942 6884 7638 7831 8862 7210 5149 3427 15 0 0 0 2018-10
SEAR 11/11 75073 53599 47402 3678 2519 6590 6022 10890 10312 9634 4580 2777 2506 288 0 0 0 2018-10
WPR 26/27 48183 18311 10952 479 6880 1928 2485 3390 3251 2964 2131 1404 750 8 0 0 0 2018-10
Total 182/194 281933 17317710529
916244 51634 19666 21410 29689 27749 27345 17883 13563 9129 6743 0 0 0
Number of Reported Measles Cases by WHO Regions
Notes: Based on data received 2018-10 and 2017-10 - This is surveillance data, hence for the last month, the data may be incomplete. * Member
States Reporting / Total Member States in Region
2017
RegionMembe
r States*
Suspected cases
Measles cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 43/47 35554 16819 8047 5039 3733 3042 2692 3238 1922 1720 1457 1001 1072 675 0 0 0 2017-10
AMR 30/35 7582 216 0 0 216 1 8 19 13 5 1 3 26 140 0 0 0 2017-10
EMR 20/21 23711 10875 3274 630 6971 1407 1168 1179 2161 2441 1469 968 78 4 0 0 0 2017-10
EUR 50/53 16219 12922 2365 3405 7152 1092 1847 2919 1705 1862 1482 1270 744 1 0 0 0 2017-10
SEAR 11/11 63810 50582 38187 7413 4982 7255 8556 12047 9430 6702 3490 2563 379 160 0 0 0 2017-10
WPR 26/27 32908 7744 2191 47 5506 640 831 1468 1298 1176 838 787 706 0 0 0 0 2017-10
Total 180/194 179784 99158 54064 16534 28560 13437 15102 20870 16529 13906 8737 6592 3005 980 0 0 0
Measles case distribution by month and WHO Region (2014-2018)
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
0
5000
10000
15000
20000
25000
30000
35000
40000
Month of onset
Mea
sles
cas
es
(Lab
+Ep
i+C
linic
al)
WPRSEAREUREMRAMRAFR
Notes: Based on data received 2018-10 - Data Source: IVB Database - This is surveillance data, hence for the last month(s), the data may be
incomplete.
Measles Incidence Rate per Million(12M period)
Top 10**
Country Cases Rate
India 60724 45.86
Ukraine 32618 734.00
Philippines 12502 121.00
Yemen 8353 302.82
Nigeria 7576 40.73
Serbia 5710 647.39
China 4291 3.06
Russian Federation
3940 27.37
Pakistan 3859 19.97
DR Congo 3558 45.19
Other countries with
high incidence rates***
Country Cases Rate
Albania 1379 471.24
Liberia 1903 412.46
Georgia 1212 308.76
Greece 3142 280.94
Lebanon 894 148.83
Romania 1766 89.29
Notes: Based on data received 2018-10 and covering the period between 2017-09 and 2018-08 - Incidence: Number of cases / population* *
100,000 - * World population prospects, 2017 revision - ** Countries with the highest number of cases for the period - *** Countries with the
highest incidence rates (excluding those already listed in the table above)
Measles cases from countries with known discrepancies between case-based and aggregate surveillance, as reported by country
Country Year Cases Data Source
DR Congo 2017 45165 SITUATION EPIDEMIOLOGIQUE DE LA ROUGEOLE EN RDC, Week of 16/10/20182018 31901
Somalia 2017 23394 Somali EPI/POL Weekly Update Week 40
2018 7765
Number of Reported Measles Cases(6M period)
Top 10*
Country Cases
India 37372
Ukraine 23335
Philippines 8472
Yemen 5509
Nigeria 3255
Serbia 2888
Sudan 2730
China 2624
DR Congo 2219
Russian Federation
2142
Notes: Based on data received 2018-10 - Surveillance data from 2018-03 to 2018-08 - * Countries with highest number of cases for the period
Measles case distribution (AFR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
0
2000
4000
6000
8000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
Uganda
OthersNigeriaNiger
LiberiaGabon
EthiopiaEquatorial GuineaDR Congo
CameroonAngola
Notes: Based on data received 2018-10 - Data Source: IVB Database
DRC has experienced a nationwide epidemic that has affected all Provinces, however, only a small proportion of the measles cases in the IDSR
aggregate reporting system are reflected in the case based data. As of 27 May 2013, South Sudan has reassigned to the Africa region (AFR)
from the Eastern Mediterranean region (EMR). For data presentation and statistical purposes, South Sudan data is presented in AFR for all the
years.
Disclaimer
This document contains data provided to WHO by member states. Note that some member states only
provide aggregate data to WHO, and for these, we are unable to generate a country profile. Some
member states report all cases at one time point for the entire year, and thus epidemiologic curves
generated are not accurate and a reporting artifact. For some countries, cases are reported by age
category, not by exact age in months and/or years. Thus, age distribution/incidence is approximate.
Cases classified as pending by countries are classified at WHO as clinically compatible at this time, and
thus numbers might different between data shown here and provided by the member state or WHO
country/regional offices.
*UN population data is used as the denominator for calculating incidence.
Measles cases: Democratic Republic of the Congo
0
1000
2000
3000
40002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Sub-national (6-59 M)
Cov: 103.5%
National SIA Sub-national SIA
0
500
1000
1500
2000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Democratic Republic of the Congo age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
50
100
150
200
Inci
den
ce r
ate
per
1,0
00
,00
0
143.3
181.8
67.4
13.5 5.1 2.3 0.3
YearConfirmed
Cases
2006 1012
2007 539
2008 214
2009 83
2010 208
2011 1651
2012 2332
2013 2527
2014 1649
2015 5029
2016 4932
2017 3617
2018 3253
Measles cases: Ethiopia
0
200
400
600
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Sub-national (9 M-14 Y)
Cov: 96.3%
Sub-national (6-179 M)
Cov: 98%
National SIA Sub-national SIA
0
100
200
300
400
500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Ethiopia age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
10
20
30
Inci
den
ce r
ate
per
1,0
00
,00
0
26.4 25.7
18.7
14
21.9
7.1
0.5
YearConfirmed
Cases
2006 1278
2007 1472
2008 3161
2009 2642
2010 6205
2011 3552
2012 4616
2013 6137
2014 14282
2015 17778
2016 4568
2017 1912
2018 947
Measles cases: Nigeria
0
1000
2000
30002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Sub-national (6 M-10 Y) NA (9-59 M)
National SIA Sub-national SIA
0
2000
4000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Nigeria age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
50
100
150
Inci
den
ce r
ate
per
1,0
00
,00
0
128.2
156
67
24.18.5 5.9 2.6
YearConfirmed
Cases
2006 1019
2007 3129
2008 10453
2009 1498
2010 9072
2011 19062
2012 6423
2013 55392
2014 6850
2015 12391
2016 17581
2017 11188
2018 5946
Measles cases: Uganda
0
100
200
300
400
500
6002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
500
1000
1500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Uganda age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
50
100
150
200
250
Inci
den
ce r
ate
per
1,0
00
,00
0
212.9 215.1
100
46.916.9 4.2 1.7
YearConfirmed
Cases
2006 1035
2007 291
2008 115
2009 86
2010 41
2011 132
2012 720
2013 460
2014 315
2015 466
2016 252
2017 892
2018 2075
Measles case distribution (AMR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
5500
Month of onset
Nu
mb
er o
f m
eas
les
case
s
Venezuela (Bolivarian Republic of)
USAPeruOthersMexicoEcuador
ColombiaChileCanadaBrazilArgentina
Notes: Based on data received 2018-10 - Data Source: IVB Database
The clustering of cases at specific time points is an artifact of reporting
Measles cases: Venezuela (Bolivarian Republic of)
0
2000
4000
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
500
1000
1500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Venezuela (Bolivarian Republic of) age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
500
1000
1500
2000
Inci
den
ce r
ate
per
1,0
00
,00
0
1678.3
600.4
171.8 121.3 33.5 13.6 6.3
YearConfirmed
Cases
2008 0
2009 0
2010 0
2011 0
2012 1
2013 0
2014 0
2015 0
2016 0
2017 727
2018 4605
The clustering of cases at specific time points is an artifact of reporting
Measles case distribution (EMR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
0
500
1000
1500
2000
2500
3000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
YemenUnited Arab EmiratesSyrian Arab Republic
SudanSomaliaSaudi Arabia
PakistanOthersIraqEgyptAfghanistan
Notes: Based on data received 2018-10 - Data Source: IVB Database
Measles cases: Pakistan
0
500
1000
1500
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
500
1000
1500
2000
2500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Pakistan age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
50
100
150
Inci
den
ce r
ate
per
1,0
00
,00
0
162.9
110
28.75.2 0.7 0.5 0
YearConfirmed
Cases
2006 35
2007 33
2008 53
2009 472
2010 1111
2011 2676
2012 8048
2013 8030
2014 1370
2015 1117
2016 2806
2017 6780
2018 2358
Measles cases: Sudan
0
200
400
600
800
10002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
500
1000
1500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Sudan age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
100
200
300
400
500
Inci
den
ce r
ate
per
1,0
00
,00
0
456.8
271.7
71.532.8 38.5 31.7 4.9
YearConfirmed
Cases
2006 274
2007 483
2008 97
2009 68
2010 613
2011 5616
2012 8521
2013 2811
2014 676
2015 3585
2016 1767
2017 665
2018 2929
Measles cases: Yemen
0
500
1000
15002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
2000
4000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Yemen age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
500
1000
1500
2000
Inci
den
ce r
ate
per
1,0
00
,00
0
1779.7
1329.7
526
125 30.7 40.5 8.1
YearConfirmed
Cases
2006 4989
2007 50
2008 53
2009 127
2010 372
2011 847
2012 2143
2013 571
2014 817
2015 465
2016 143
2017 2101
2018 7285
Measles case distribution (EUR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
UkraineSerbiaRussian FederationRomaniaOthersKyrgyzstan
ItalyGermanyGeorgia
FranceBosniaand
Herzegovina
Notes: Based on data received 2018-10 - Data Source: IVB Database
Measles cases: Georgia
0
100
200
300
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
100
200
300
400
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Georgia age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
500
1000
1500
2000
2500
Inci
den
ce r
ate
per
1,0
00
,00
0
2475.4
808.3477 584.9
379 432.444.7
YearConfirmed
Cases
2006 8
2007 2
2008 55
2009 23
2010 22
2011 64
2012 30
2013 7868
2014 3190
2015 430
2016 14
2017 96
2018 1129
Measles cases: Russian Federation
0
200
400
600
800
10002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
200
400
600
800
1000
1200
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Russian Federation age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
50
100
150
200
250
Inci
den
ce r
ate
per
1,0
00
,00
0
243.2
144.1
56.728 29.7 24.8
6.8
YearConfirmed
Cases
2006 1129
2007 172
2008 27
2009 101
2010 152
2011 783
2012 1975
2013 2501
2014 3263
2015 635
2016 179
2017 926
2018 3313
Measles cases: Ukraine
0
2000
4000
60002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
2000
4000
6000
<1 year 1-4 years 5-9 years 10-14 years 15-19 years 20-29 years 30+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Ukraine age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
1000
2000
3000
4000
Inci
den
ce r
ate
per
1,0
00
,00
0
3862.6
2872.32612.3
2077.4
741 517.2260.5
YearConfirmed
Cases
2006 945
2007 232
2008 41
2009 24
2010 42
2011 1313
2012 12744
2013 3308
2014 2326
2015 141
2016 90
2017 4782
2018 29464
Measles case distribution (SEAR (excl. India)), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
0
500
1000
1500
2000
2500
3000
3500
Month of onset
Nu
mb
er o
f m
eas
les
case
s
Timor-LesteThailandSri LankaNepalMyanmar
MaldivesIndonesiaDPR KoreaBhutanBangladesh
Notes: Based on data received 2018-10 - Data Source: IVB Database
Measles cases: Indonesia
0
2000
4000
60002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Sub-national (9 M-15 Y)
Cov: 100.5%
National SIA Sub-national SIA
0
100
200
300
400
500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Indonesia age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
10
20
Inci
den
ce r
ate
per
1,0
00
,00
0
22.2 20.818.4
11.7
5.5
1.1 0.2
YearConfirmed
Cases
2006 21911
2007 20837
2008 16417
2009 21008
2010 23471
2011 23510
2012 16786
2013 10093
2014 9498
2015 6209
2016 7204
2017 11389
2018 1556
Measles case distribution (SEAR, India), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
0
5000
10000
15000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
India
Notes: Based on data received 2018-10 - Data Source: IVB Database
Measles cases: India
0
5000
10000
15000
20000
25000
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Rollover-Nat (9 M-15 Y)
National SIA Sub-national SIA
0
2000
4000
6000
8000
10000
12000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
India age distribution, vaccination status, and incidence, 2017-09 to 2018-08
020406080100
120
Inci
den
ce r
ate
per
1,0
00
,00
0
108.999.4
84.5
24.1
5.2 1.7 0.3
YearConfirmed
Cases
2014 80306
2015 83026
2016 70798
2017 57392
2018 48502
Measles case distribution (WPR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
22000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
Viet NamSingaporeRepublic of KoreaPhilippinesPapua New Guinea
Others
MongoliaMalaysiaJapan
ChinaAustralia
Notes: Based on data received 2018-10 - Data Source: IVB Database
Measles cases: Philippines
0
1000
2000
30002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
2000
4000
6000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Philippines age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
500
1000
1500
Inci
den
ce r
ate
per
1,0
00
,00
0
1556.5
548.2
94.3 43.9 73.3 39 5
YearConfirmed
Cases
2006 216
2007 612
2008 838
2009 1351
2010 6363
2011 6519
2012 1441
2013 4855
2014 53906
2015 2021
2016 647
2017 1605
2018 11670
Distribution of measles genotypes(last 12 months)
Notes: Data Source: MeaNS database (Genotypes) and IVB Database (Incidence) as of 2018-10-17 and covering the period 2017-09-01 to
2018-08-31 - Pie charts proportional to the number of sequenced viruses
Rubella
Number of Reported Rubella Cases by WHO Regions
2018
RegionMember States*
Rubella cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 41/47 2593 0 0 2593 337 362 560 353 344 218 221 161 37 0 0 0 2018-10
AMR 24/35 2 0 0 2 0 1 0 1 0 0 0 0 0 0 0 0 2018-10
EMR 20/21 876 92 49 735 103 117 160 128 126 90 89 56 7 0 0 0 2018-10
EUR 36/53 662 585 6 71 82 97 75 97 93 81 63 74 0 0 0 0 2018-10
SEAR 11/11 1490 0 55 1435 233 254 345 262 218 93 36 49 0 0 0 0 2018-10
WPR 15/27 2549 142 47 2360 118 107 291 511 751 338 255 178 0 0 0 0 2018-10
Total 147/194 8172 819 157 7196 873 938 1431 1352 1532 820 664 518 44 0 0 0
2017
RegionMember States*
Rubella cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 42/47 4569 0 0 4569 278 515 586 328 343 372 212 331 388 647 459 110 2018-10
AMR 26/35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2018-10
EMR 20/21 914 43 1 870 76 111 121 106 156 112 49 22 25 50 47 39 2018-10
EUR 30/53 703 568 19 116 59 60 87 69 85 58 54 47 38 54 46 46 2018-10
SEAR 11/11 7676 0 2257 5419 583 1100 1576 1242 808 357 325 512 341 361 253 218 2018-10
WPR 14/27 2287 258 162 1867 154 201 342 307 295 194 195 128 115 81 110 165 2018-10
Total 143/194 16149 869 2439 12841 1150 1987 2712 2052 1687 1093 835 1040 907 1193 915 578
Notes: Based on data received 2018-10 - This is surveillance data, hence for the last month, the data may be incomplete. * Member States
Reporting / Total Member States in Region
Rubella Case Distribution by Month and WHO Region (2015-2018)
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
5500
Month of onset
Ru
bel
la c
ases
(La
b+E
pi+
Clin
ical
)
WPRSEAREUREMRAMRAFR
Notes: Based on data received 2018-10 - Data Source: IVB Database - This is surveillance data, hence for the last month(s), the
data may be incomplete.
Rubella cases: AFR
0
200
400
6002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(I
gM+
on
ly)
AFR Rubella Case Distribution (October 2016-September 2018)
0
200
400
600
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(IgM
+ o
nly
)
AFR Age distribution of Rubella IgM+ cases by vaccine introduction status in the National EPI Programme (October 2017-September 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
South Africa No 1086 29
Ethiopia No 697 18
Nigeria No 455 12
DR Congo No 432 11
Others - 362 10
Uganda No 307 8
Cote d'Ivoire No 174 5
Mali No 95 2
Congo No 90 2
Liberia No 59 2
Chad No 52 1
Notes: Based on data received 2018-10 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Rubella cases: EMR
0
50
100
1502
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
EMR Rubella Case Distribution (October 2016-September 2018)
020406080
100120
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) EMR Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (October 2017-September 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
Sudan No 324 32
Yemen 2015 271 27
Pakistan No 217 21
Saudi Arabia 1991 45 4
Afghanistan No 43 4
Others - 37 4
Iran (Islamic Republic of)
2004 36 4
United Arab Emirates
1985 12 1
Egypt 1999 9 1
Iraq 1995 9 1
Tunisia 2004 9 1
Notes: Based on data received 2018-10 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Rubella cases: EUR
0
20
40
60
80
1002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
EUR Rubella Case Distribution (October 2016-September 2018)
0
100
200
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) EUR Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (October 2017-September 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
Poland 1988 458 57
Ukraine 2001 186 23
Germany 1991 58 7
Others - 26 3
Italy 1972 24 3
Austria 1973 20 2
Turkey 2006 11 1
Kyrgyzstan 2001 10 1
Ireland 1971 5 1
Romania 2002 5 1
Russian Federation
2000 5 1
Notes: Based on data received 2018-10 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016. Spikes in age-distribution curve are an artifact of reporting by age bands ( 0=<1 yrs, 2=1-4 yrs, 7=5-9 yrs, 12=10-14 yrs, 17=15-19
yrs, 25=20-29 yrs, 45=30+yrs) instead of by age from some member states.
Rubella cases: SEAR (excl. India)
0
200
400
6002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
SEAR (excl. India) Rubella Case Distribution (October 2016-September 2018)
0
50
100
150
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) SEAR (excl. India) Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (October 2017-September 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
Indonesia No 1498 81
Bangladesh 2012 273 15
Nepal 2013 35 2
Thailand 1993 18 1
Myanmar 2015 10 1
Timor-Leste 2016 8 0
Bhutan 2006 2 0
Sri Lanka 1996 1 0
Notes: Based on data received 2018-10 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Rubella cases: Bangladesh
0
20
40
602
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
ClinicalEpi
Lab
Month of onset
Nu
mb
er o
f ca
ses
SIA (9 M-<5 Y)
Cov: 101%
National SIA Sub-national SIA
0
20
40
60
80
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Bangladesh age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
5
10
15
20
Inci
den
ce r
ate
per
1,0
00
,00
0
18.7
64.3
1.8 1.3 0.4 0.2
YearConfirmed
Cases
2015 189
2016 165
2017 298
2018 224
Rubella cases: SEAR, India
0
200
400
600
800
10002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
SEAR, India Rubella Case Distribution (October 2016-September 2018)
0
10
20
30
40
50
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) SEAR, India Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (October 2017-September 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
India No 477 100
Notes: Based on data received 2018-10 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Rubella cases: Indonesia
0
200
400
600
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
ClinicalEpi
Lab
Month of onset
Nu
mb
er o
f ca
ses
SIA (9 M-15 Y)
Cov: 100.5%
National SIA Sub-national SIA
0
100
200
300
400
500
600
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Indonesia age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
5
10
15
20
25
Inci
den
ce r
ate
per
1,0
00
,00
0
15.1
10.7
23
18.8
7.2
2.40.6
YearConfirmed
Cases
2015 1379
2016 1170
2017 4349
2018 862
Rubella cases: WPR
0
200
400
600
8002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
WPR Rubella Case Distribution (October 2016-September 2018)
0
50
100
150
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) WPR (Excl. China) Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (October 2017-September 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
China 2008 2592 89
Malaysia 1998 125 4
Philippines 2010 84 3
Viet Nam 2015 51 2
Japan 1989 19 1
Singapore 1990 15 1
Lao People's Democratic
Republic2012 11 0
Republic of Korea 1982 3 0
Cambodia 2013 2 0
Mongolia 2009 2 0
Others - 1 0
Notes: Based on data received 2018-10 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Rubella cases: China
0
200
400
600
8002
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
ClinicalEpi
Lab
Month of onset
Nu
mb
er o
f ca
ses
YearConfirmed
Cases
2014 11887
2015 8247
2016 4477
2017 1601
2018 2289
Age distribution not available from China
Rubella cases: Philippines
0
20
40
60
802
01
6-0
9
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
ClinicalEpi
Lab
Month of onset
Nu
mb
er o
f ca
ses
0
20
40
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Philippines age distribution, vaccination status, and incidence, 2017-09 to 2018-08
0
2
4
6
8
Inci
den
ce r
ate
per
1,0
00
,00
0
7
2.5
0.5 0.6
2.1
0.80.1
YearConfirmed
Cases
2014 343
2015 154
2016 165
2017 443
2018 82
Distribution of rubella genotypes(last 12 months)
Notes: Data Source: RubNS database (Genotypes) and IVB Database (Incidence) as of 2018-10-17 and covering the period 2017-09-01 to
2018-08-31 - Pie charts proportional to the number of sequenced viruses
Laboratory
Measles and Rubella IgM Data Summary
2017
RegionMember States*
Specimens received
Measles tested
Measles positive n(%)
Measles equivocal n(%)
Measles negative n(%)
Rubella tested
Rubella positive n(%)
Rubella equivocal n(%)
Rubella negative n(%)
AFR 40/47 35178 35178 4633 (13) 665 (2) 29880 (85) 29602 4962 (17) 1260 (4) 23380 (79)
AMR 27/35 9103 8757 635 (7) 58 (1) 7452 (85) 7946 329 (4) 107 (1) 6920 (87)
EMR 20/21 36251 34782 10561 (30) 127 (0) 24094 (69) 32726 1105 (3) 99 (0) 31522 (96)
EUR 38/53 42450 37192 13748 (37) 272 (1) 22642 (61) 26322 434 (2) 66 (0) 25736 (98)
SEAR 11/11 35379 32335 13177 (41) 781 (2) 20062 (62) 20383 4831 (24) 741 (4) 14804 (73)
WPR 27/27 16467 15211 2100 (14) 333 (2) 11952 (79) 12656 606 (5) 418 (3) 10748 (85)
Total 163/194 174828 163455 44854 (27) 2236 (1) 116082 (71) 129635 12267 (9) 2691 (2) 113110 (87)
2018
RegionMember States*
Specimens received
Measles tested
Measles positive n(%)
Measles equivocal n(%)
Measles negative n(%)
Rubella tested
Rubella positive n(%)
Rubella equivocal n(%)
Rubella negative n(%)
AFR 37/47 22876 22876 4839 (21) 569 (2) 17468 (76) 16606 2716 (16) 969 (6) 12921 (78)
AMR 27/35 12645 11881 1100 (9) 115 (1) 10253 (86) 10337 348 (3) 236 (2) 9324 (90)
EMR 20/21 28772 24784 8612 (35) 142 (1) 16030 (65) 21732 1054 (5) 422 (2) 20256 (93)
EUR 37/53 43036 39003 13407 (34) 236 (1) 25098 (64) 23091 553 (2) 52 (0) 22465 (97)
SEAR 11/11 19450 14693 5300 (36) 378 (3) 9005 (61) 9987 1521 (15) 292 (3) 8171 (82)
WPR 27/27 22608 18218 3182 (17) 404 (2) 9926 (54) 14321 428 (3) 299 (2) 8237 (58)
Total 159/194 149387 131455 36440 (28) 1844 (1) 87780 (67) 96074 6620 (7) 2270 (2) 81374 (85)
Notes: Based on data received 2018-10 - * Member States Reporting / Total Member States in Region
Measles and Rubella IgM Data Summary
2018
RegionMember States*
Specimens received
Measles tested
Measles positive n(%)
Measles equivocal n(%)
Measles negative n(%)
Rubella tested
Rubella positive n(%)
Rubella equivocal n(%)
Rubella negative n(%)
AFR 37/47 22876 22876 4839 (21) 569 (2) 17468 (76) 16606 2716 (16) 969 (6) 12921 (78)
AMR 27/35 12645 11881 1100 (9) 115 (1) 10253 (86) 10337 348 (3) 236 (2) 9324 (90)
EMR 20/21 28772 24784 8612 (35) 142 (1) 16030 (65) 21732 1054 (5) 422 (2) 20256 (93)
EUR 37/53 43036 39003 13407 (34) 236 (1) 25098 (64) 23091 553 (2) 52 (0) 22465 (97)
SEAR 11/11 19450 14693 5300 (36) 378 (3) 9005 (61) 9987 1521 (15) 292 (3) 8171 (82)
WPR 27/27 22608 18218 3182 (17) 404 (2) 9926 (54) 14321 428 (3) 299 (2) 8237 (58)
Total 159/194 149387 131455 36440 (28) 1844 (1) 87780 (67) 96074 6620 (7) 2270 (2) 81374 (85)
Based on data received 2017-10 - * Member States Reporting / Total Member States in Region
2017
RegionMember States*
Specimens received
Measles tested
Measles positive n(%)
Measles equivocal
n(%)
Measles negative n(%)
Rubella tested
Rubella positive n(%)
Rubella equivocal
n(%)
Rubella negative n(%)
AFR 37/47 25697 25697 3231 (13) 587 (2) 21879 (85) 21765 3629 (17) 881 (4) 17255 (79)
AMR 25/35 8458 8158 167 (2) 79 (1) 4941 (61) 7763 242 (3) 91 (1) 4804 (62)
EMR 20/21 24329 23781 7990 (34) 111 (0) 15680 (66) 21554 1350 (6) 75 (0) 20129 (93)
EUR 37/53 28342 24803 10292 (41) 210 (1) 13951 (56) 16320 299 (2) 41 (0) 15921 (98)
SEAR 11/11 25348 22031 8609 (39) 425 (2) 11922 (54) 12858 3078 (24) 443 (3) 9336 (73)
WPR 27/27 11135 10379 1291 (12) 257 (2) 8816 (85) 8761 474 (5) 285 (3) 7996 (91)
Total 157/194 123309 114849 31580 (27) 1669 (1) 77189 (67) 89021 9072 (10) 1816 (2) 75441 (85)
Based on data received 2018-10 - * Member States Reporting / Total Member States in Region
Performance of Surveillance
Surveillance sensitivity reporting rate of measles and rubella (12 months, discarded cases* per 100,000 population)
Notes: Based on data received 2018-10 and covering the period between 2017-09 and 2018-08 - Target: >= 2 discarded cases* / 100,000
population** - * Suspected cases investigated and discarded as non-measles non-rubella using laboratory testing and/or epidemiological linkage
to another etiology ** World population prospects, 2017 revision
Supplementary Immunization Activities
Next 6 months MMR, MR and Measles campaigns
Region Name Activity Type Year StartDate EndDateAge
Group(s)Extent Target
EMR Djibouti FollowUp Measles 2018 2018-11-01 - 9-59 M National 101885
SEAR India CatchUp MR 2018 2018-11-01 2018-12-31 9 M-15 Y Rollover-Nat 119400000
SEAR Bhutan CatchUp MR 2018 2018-12-01 - 9 M-40 Y Sub-national 1e+05
SEAR India CatchUp MR 2019 2019-01-01 - 9 M-15 Y Rollover-Nat 49300000
SEAR Bangladesh FollowUp MR 2019 2019-02-01 - 9-59 M National 15656579
Link to global Measles SurveillanceHQ website
• AFR Monthly feedback tables
• AMR: Weekly bulletin (published every Friday)
• EMR: Home page
• EUR : Periodical bulletin
Monthly data
• SEAR: Monthly bulletin
EPI country fact sheets
• WPR: Monthly Bulletin
Country profiles
(Switch to presentation mode if links are inactive)
Regional Bulletins and Newsletters